Cobra Biologics and Alligator Bioscience have entered into a manufacturing services and supply agreement for the production of monoclonal antibody drug product for preclinical and Phase I and II trials.   Cobra will provide cell line development through its maxXpress service, GMP cell banking, analytical and process development, scale-up, toxicology and GMP supplies, as well as stability studies and QP release for clinical trials.   Alligator will utilize the maxXpress service, which combines th...